Hypermarcas (OTCMKTS:HYPMY) Trading Down 9% – Here’s Why

Shares of Hypermarcas (OTCMKTS:HYPMY) were down 9% during trading on Tuesday . The company traded as low as $4.25 and last traded at $4.25. Approximately 413 shares changed hands during mid-day trading, a decline of 88% from the average daily volume of 3,427 shares. The stock had previously closed at $4.67.

Hypermarcas Trading Down 7.7%

The company has a debt-to-equity ratio of 0.61, a current ratio of 1.27 and a quick ratio of 0.84. The stock’s 50-day moving average is $4.52 and its two-hundred day moving average is $4.44. The company has a market cap of $2.81 billion, a P/E ratio of 19.30 and a beta of 0.72.

Hypermarcas (OTCMKTS:HYPMY) last released its quarterly earnings results on Wednesday, November 12th. The company reported $0.13 earnings per share for the quarter. Hypermarcas had a return on equity of 6.89% and a net margin of 12.03%.The firm had revenue of $408.83 million for the quarter.

Hypermarcas Company Profile

Hypermarcas SA is a Brazil-based consumer health and pharmaceutical company whose shares trade over the counter in the United States under the symbol HYPMY. Founded in the early 2000s and headquartered in Rio de Janeiro, the company operates as a holding group for a broad portfolio of branded products in the healthcare and personal care sectors.

Through its various subsidiaries, Hypermarcas develops, manufactures and markets prescription and over-the-counter medications, alongside personal care, baby care, home care and nutritional supplement products.